Page last updated: 2024-10-26

diethylcarbamazine and Carbamoyl-Phosphate Synthase I Deficiency Disease

diethylcarbamazine has been researched along with Carbamoyl-Phosphate Synthase I Deficiency Disease in 1 studies

Diethylcarbamazine: An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.

Carbamoyl-Phosphate Synthase I Deficiency Disease: A urea cycle disorder manifesting in infancy as lethargy, emesis, seizures, alterations of muscle tone, abnormal eye movements, and an elevation of serum ammonia. The disorder is caused by a reduction in the activity of hepatic mitochondrial CARBAMOYL-PHOSPHATE SYNTHASE (AMMONIA). (Menkes, Textbook of Child Neurology, 5th ed, pp50-1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
VERNON, S1

Other Studies

1 other study available for diethylcarbamazine and Carbamoyl-Phosphate Synthase I Deficiency Disease

ArticleYear
Nutritional melalgia, a deficiency vascular disease.
    Journal of the American Medical Association, 1950, Jul-01, Volume: 143, Issue:9

    Topics: Carbamoyl-Phosphate Synthase I Deficiency Disease; Cardiovascular System; Deficiency Diseases; Dieth

1950